Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 13026 - 13050 of 14357 in total

VGB-R04

VGB-R04 is an adeno-associated viral vector delivering human FIX Padua gene.
Investigational

CTX130

CTX130 is an allogeneic CRISPR/Cas9-mediated genetically modified CAR T cell therapy targeting CD70 antigen.
Investigational

Allogeneic natural killer cells

Investigational

AVR-RD-05

AVR-RD-05 is a gene therapy comprising genetically modified autologous stem cells transduced ex vivo with a lentiviral vector encoding the human iduronate-2-sulfatase (IDS) enzyme. It is under investigation for the treatment of Hunter Syndrome (Mucopolysaccharidosis Type II, MPSII).
Investigational

MaaT013

MaaT013 is an allogeneic fecal microbiota therapy. It is being investigated for the treatment of Graft-Versus-Host Disease.
Investigational

ATIR101

ATIR101 is a haploidentical, naïve cell-enriched T-cell therapy.
Investigational

Allogeneic human pancreatic islets of Langerhans

Investigational

ssCART-19 cells

ssCART-19 cells consist of autologous anti-CD19 Chimeric Antigen Receptors (CAR)-T cells expressing a short hairpin RNA (shRNA) against interleukin-6 (IL-6).
Investigational

Epidermal Growth Factor Receptor variant III (EGFRvIII) chimeric antigen receptor T cells

Investigational

Autologous CD4+CD25hiFoxP3+regulatory T cells

Investigational

Avoplacel

Avoplacel (PLX-R18) is an allogeneic cell therapy under investigation for the treatment of acute radiation syndrome.
Investigational

Ex vivo expanded autologous human corneal epithelial cells containing stem cells

Holoclar (ex vivo expanded autologous human corneal epithelial cells containing stem cells) is a stem cell therapy used to treat limbal stem cell deficiencies.
Investigational

Rugonersen

Rugonersen is a locked nucleic acid antisense oligonucleotide under investigation for the treatment of Angelman Syndrome.
Investigational

Ulefnersen

Investigational

RC88

RC88 is an antibody-drug conjugate comprising a humanized anti-mesothelin monoclonal antibody conjugated to monomethyl auristatin E (MMAE).
Investigational

HLX-58

HLX-58 is an investigational monoclonal antibody targeted against claudin 18.2.
Investigational

SHR-A1904

SHR-A1904 is under investigation in clinical trial NCT04877717 (A Study of SHR-A1904 in Patients With Advanced Solid Cancer).
Investigational

rAAV1-CB-hAAT

rAAV1-CB-hAAT is a recombinant adeno-associated virus alpha 1-antitrypsin vector.
Investigational

BVX001

BVX001 is a a novel, first-in-class CD33/CD7-directed antibody-drug conjugate.
Investigational

Celivarone

Celivarone is under investigation in clinical trial NCT00233441 (Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 Mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/flutter).
Investigational
Matched Description: … investigation in clinical trial NCT00233441 (Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and …

Exisulind

Investigational

Acetyl Dithranol

Experimental

CRA_10762

Experimental

Oxidized Acetyl Dithranol

Experimental

(2R,3R,4S,5R)-2-acetamido-3,4-dihydroxy-5-hydroxymethyl-piperidine

Experimental
Displaying drugs 13026 - 13050 of 14357 in total